Completed PHASE1 INTERVENTIONAL 1-arm NCT02056496

Pharmacokinetics and Bioavailability of Pomegranate Phenolics and Urolithins in Healthy Subjects. (POMEkinetics)

Pharmacokinetics and Bioavailability of Pomegranate Phenolics and Gut Microbiota-derived Metabolites (Urolithins) in Overweight Subjects. Comparison Between Two Pomegranate Extracts

Sponsor: National Research Council, Spain

Conditions Healthy

Interventions Pomegranate extract

Updated 5 times since 2017 Last updated: Apr 13, 2015 Started: Jan 31, 2014 Primary completion: Jan 31, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02056496, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by National Research Council, Spain, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Research Council, Spain
Universidad Católica San Antonio de Murcia

Data source: National Research Council, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain